0000899243-19-025927.txt : 20191024
0000899243-19-025927.hdr.sgml : 20191024
20191024191249
ACCESSION NUMBER: 0000899243-19-025927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191023
FILED AS OF DATE: 20191024
DATE AS OF CHANGE: 20191024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BELOFF GREGG
CENTRAL INDEX KEY: 0001171002
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37566
FILM NUMBER: 191167000
MAIL ADDRESS:
STREET 1: C/O CERULEAN PHARMA INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNLOGIC, INC.
CENTRAL INDEX KEY: 0001527599
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261824804
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-401-9975
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
STREET 2: SUITE 402
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Mirna Therapeutics, Inc.
DATE OF NAME CHANGE: 20110809
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-23
0
0001527599
SYNLOGIC, INC.
SYBX
0001171002
BELOFF GREGG
C/O SYNLOGIC, INC.
301 BINNEY STREET, SUITE 402
CAMBRIDGE
MA
02142
0
1
0
0
See Remarks
Stock Option (right to buy)
2.30
2019-10-23
4
A
0
50000
0.00
A
2029-10-23
Common Stock
50000
50000
D
The option vest with respect to 25% of the shares on a date that is 6 months from the date of grant, with the remaining shares to vest in equal monthly installments over the following 18 months, subject to the Reporting Person continuing to provide services to the Issuer as Interim Chief Financial Officer through each such vesting date.
Interim Chief Financial Officer
/s/ Daniel Bagliebter, Attorney-in-fact
2019-10-24